Researchers at Dana-Farber’s Center for Cancer Systems Biology produced a new human interactome map, based on a systematic screen of 13,000 human proteins that uncovered 14,000 protein-protein interactions.
Tags: Genomics, Genetics
Tags: PatientSupport, Survivorship
Former “NBC Nightly News” anchor Tom Brokaw, who was diagnosed with multiple myeloma in 2013, toured Dana-Farber and spoke at the Visiting Committee dinner.
Dr. Anne Partridge commented on a study that found double mastectomies do not improve the chances of survival for women at average risk of breast cancer recurrence.
Dr. Patrick Wen commented on a study about an electrical device glued to the scalp that can slow glioblastoma growth and prolong survival.
Dr. Edward J. Benz, Jr., talked about research to develop treatments for cancer that are more efficient and less toxic, by specifically targeting tumors using genetic analysis.
Tags: BasicResearch, TargetedTherapy
Drs. Richard Stone, Jeff Golden, and Robert Soiffer collaborated on a study using Rapid Heme Panel, a high-tech genetic test that provides critical information for treating blood cancer patients.
Dr. F. Stephen Hodi led a clinical trial study that found patients with metastatic melanoma who were treated with ipilimumab, survived 50 percent longer if they simultaneously received an immune stimulant.
Dana-Farber was recognized as a Leader in LGBT Healthcare Equality by the Human Rights Campaign Foundation, the educational arm of the country's largest lesbian, gay, bisexual and transgender civil rights organization.
Tags: Honors, PatientSupport, YawkeyCenter
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: